1. Home
  2. > Method Of Mobile Manufacturing Process

Method Of Mobile Manufacturing Process

Tisagenlecleucel is a cd19-specific chimeric antigen receptor car-t cell therapy approved for patients aged 25 years with relapsed or refractory b cell precursor acute lymphoblastic leukemia b-all and adults with relapsed or refractory diffuse large b cell lymphoma dlbcl. the initial tisagenlecleucel manufacturing process technology was developed at an academic center and was .

Get Price

Online Message

Contact Us

If you are interested in the preferential price and technical parameters of our products, please leave your details, and we will arrange a professional technical manager to reply you within 24 hours.

  • Experts make plans Experts make plans
  • Customized production line Customized production line
  • After sales guaranteed After sales guaranteed

Get Latest Price

[email protected]

Zhengzhou hi tech Industrial Development Zone, China